“PROSPECTS OF COMBINING INTERLEUKIN-2 WITH IMMUNE CHECKPOINT INHIBITORS FOR CANCER THERAPY”, Вопр. онкол., vol. 66, no. 1, pp. 23–28, Jan. 2020, doi: 10.37469/0507-3758-2020-66-1-23-28.